Company Filing History:
Years Active: 2001-2007
Title: The Innovations of Takamune Takahashi
Introduction
Takamune Takahashi is a notable inventor based in Nashville, TN (US). He has made significant contributions to the field of biomedical research, particularly in the regulation of angiogenesis. With a total of 2 patents to his name, his work has the potential to impact therapeutic strategies for various diseases.
Latest Patents
Takahashi's latest patents focus on the modulation of endothelial cell surface receptor activity in the regulation of angiogenesis. One of his patents describes a method of modulating angiogenesis in a vertebrate subject. This method involves administering an ECRTP/DEP-1 activity-modulating amount of a composition to the subject. The composition contacts the ECRTP/DEP-1 within the vertebrate subject, thereby modulating angiogenesis. Additionally, the composition may include a monoclonal antibody that preferentially binds to ECRTP/DEP-1. Another patent outlines similar methods for screening modulators of ECRTP/DEP-1, further emphasizing his innovative approach to this critical biological process.
Career Highlights
Takahashi is affiliated with Vanderbilt University, where he conducts his research and development. His work at this prestigious institution has allowed him to explore various aspects of angiogenesis and its implications in health and disease. His innovative methods and findings contribute to the broader scientific community's understanding of vascular biology.
Collaborations
Some of Takahashi's notable coworkers include Thomas O Daniel and Raymond Mernaugh. Their collaborative efforts enhance the research environment and foster innovation in their respective fields.
Conclusion
Takamune Takahashi's contributions to the field of angiogenesis through his patents and research at Vanderbilt University highlight his role as a significant inventor. His work not only advances scientific knowledge but also holds promise for future therapeutic applications.